摘要
嘌呤受体分为腺苷作用的P1受体和ATP作用的P2受体两大类;P2受体又分为P2X(离子通道受体)和P2Y(G蛋白耦联受体)。多种嘌呤受体亚型表达于内分泌胰腺,并参与调节胰岛素的分泌。嘌呤受体和配体与糖尿病及其并发症的发病机制密切相关,并可能成为糖尿病及其并发症治疗的新靶点。
Purinergic receptors are divided into P1 (adenosine) and P2 (ATP) receptors. P2 receptor are divided into two subtypes,namely P2X (ligand-gated ion channels) and P2Y (G- protein coupled) receptors. Several kinds of purinoceptor subtypes have been expressed in endocrine pancreas and participate in regulating the secretion of insulin. Purinoceptor and ligand are correlated with pathogenesis of diabetes mellitus and complications and make it possible to provide a new target to treat diabetes mellitus and complications.
出处
《中国药理学通报》
CAS
CSCD
北大核心
2009年第10期1275-1277,共3页
Chinese Pharmacological Bulletin
基金
国家自然科学基金资助课题(No30860086
30660048
30460040)
教育部高校博士点专项科研基金资助课题(No20070403007)
江西省自然科学基金资助课题(No0640042)
江西省教育厅科技研究资助项目(No赣教技字[2007]60号和GGJ08049)
关键词
嘌呤受体
核苷酸
内分泌胰腺
胰岛素分泌
糖尿病
治疗
purinoceptors
nucleotide
endocrine pancreas
se-cretion of insulin
diabetes mellitus
therapeutics